Galectin-3, Human, Recombinant, E. coli

Recombinant, human galectin-3 expressed in E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.

Recombinant, human galectin-3 expressed in and purified from E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.

Toxicity: Standard Handling (A)

Lyophilized from diH₂O.

Following reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.

Reconstitute in sterile PBS. For use in carbohydrate binding studies, lactose should be removed by dialysis.

Legendre, H., et al. 2003. Mod. Pathol.16, 491.
Maeda, M., et al. 2003. J. Biol. Chem.278, 18938.
Stock, M., et al. 2003. J. Biol. Chem.278, 17360.
Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta1572, 232.
Iurisci, I., et al. 2000. Clin. Cancer Res.6, 1389.
Oda, Y., et al. 1991. Gene99, 279.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany